SciBase Receives First Order in Austria
SciBase Receives First Order in Austria
STOCKHOLM, May 30, 2024 /PRNewswire/ -- SciBase Holding AB ("SciBase") (STO: SCIB), a leading developer of artificial intelligence (AI)-based solutions for skin disorders, is pleased to announce that it has received the first order for a Nevisense system with electrodes in Austria.
斯德哥尔摩，2024 年 5 月 30 日 /PRNewswire/-- SciBase Holding AB（“SciBase”） （停止：SCIB）是基于人工智能（AI）的皮肤病解决方案的领先开发商，很高兴地宣布，它已在奥地利收到了第一批带电极的Nevisense系统的订单。
SciBase has since the end of the first quarter, following the strong development in Germany, expanded into Austria and Switzerland. In March, a sales representative was hired in Austria with previous experience in establishing businesses in dermatology and he is now responsible for establishing Nevisense in these markets. Nevisense has been presented and demonstrated in local congresses in Austria, which now is beginning to yield positive results.
继德国的强劲发展之后，SciBase自第一季度末以来已扩展到奥地利和瑞士。3月，奥地利聘请了一位销售代表，该代表以前曾在皮肤科领域建立业务，现在他负责在这些市场建立Nevisense。Nevisense已在奥地利的地方代表大会上进行了展示和演示，现在已开始取得积极成果。
"It is pleasing to see that our strategy and belief in Nevisense is beginning to bear fruit. Joachim Kaiser, our sales representative in Austria, does a fantastic job and has managed to get a first sale in a short time. This strengthens our belief that Austria and Switzerland can develop into good markets for us," says Pia Renaudin CEO of SciBase.
“令人高兴的是，我们对Nevisense的战略和信念开始取得成果。我们在奥地利的销售代表Joachim Kaiser做得非常出色，并在短时间内成功实现了第一笔销售。这坚定了我们的信念，即奥地利和瑞士可以为我们发展成为良好的市场。” SciBase首席执行官皮亚·雷诺丁说。
For additional information, please contact:
Pia Renaudin, VD, tel. +46732069802, e-mail: [email protected]
欲了解更多信息，请联系：
Pia Renaudin，VD，电话 +46732069802，电子邮件：[email protected]
Certified Advisor (CA):
认证顾问 (CA)：
Vator Securities
Tel: +46 8 580 065 99
Email: [email protected]
Vator 证券
电话：+46 8 580 065 99
电子邮件：[电子邮件保护]
About SciBase:
关于 SciBase：
SciBase is a global medical technology company, specializing in early detection and prevention in dermatology. SciBase develops and commercializes Nevisense, a unique point-of-care platform that combines AI (artificial intelligence) and advanced EIS technology to elevate diagnostic accuracy, ensuring proactive skin health management.
SciBase 是一家全球医疗技术公司，专门从事皮肤病学的早期发现和预防。SciBase 开发并商业化了 Nevisense，这是一个独特的即时护理平台，它结合了人工智能（人工智能）和先进的 EIS 技术，可提高诊断准确性，确保积极的皮肤健康管理。
Our commitment is to minimize patient suffering, allowing clinicians to improve and save lives through timely detection and intervention and reduce healthcare costs.
我们的承诺是最大限度地减少患者的痛苦，使临床医生能够通过及时的检测和干预来改善和挽救生命，并降低医疗成本。
Built on more than 20 years of research at Karolinska Institute in Stockholm, Sweden, SciBase is a leader in dermatological advancements.
SciBase建立在瑞典斯德哥尔摩卡罗林斯卡研究所20多年的研究基础上，是皮肤病学进步领域的领导者。
The company has been on the Nasdaq First North Growth Market exchange since June 2, 2015. Learn more at . All press releases and financial reports can be found here:
该公司自2015年6月2日起在纳斯达克第一北方成长市场交易所上市。要了解更多，请访问。所有新闻稿和财务报告都可以在这里找到：
This information was brought to you by Cision
这些信息是由 Cision 带给你的
The following files are available for download:
以下文件可供下载：
|
AT first order |
|
第一次下单 |